Exploring the protective mechanisms of insulin receptor substrate-1 under conditions of hypoxic-ischemic injury

Stroke is a major cause of death and disability worldwide, with neuronal death as a key factor. IRS-1, a core insulin signaling protein, may support neuronal survival under hypoxic conditions. In this study, primary cortical neurons were subjected to oxygen-glucose deprivation (OGD) followed by 24 hours of reoxygenation to mimic ischemic injury. Cell viability was significantly reduced, with approximately 50% neuronal death observed under these conditions. Interestingly, while IRS-1 mRNA levels remained relatively stable, a marked and time-dependent decrease in IRS-1 protein was detected, suggesting post-transcriptional regulation. Immunofluorescence confirmed the loss of IRS-1 expression in neurons after OGD. To explore the mechanism of IRS-1 degradation, we applied MG132 (a proteasome inhibitor), 3-MA (an autophagy inhibitor), and Rapamycin (an autophagy activator via mTOR inhibition). While MG132 improved cell viability, it did not restore IRS-1 levels, indicating that proteasomal degradation was not the dominant pathway. In contrast, inhibition of autophagy via 3-MA significantly increased IRS-1 expression and decreased LC3-II levels, a marker of autophagic flux. Rapamycin, surprisingly, also partially restored IRS-1 protein levels despite promoting autophagy, suggesting a modulatory effect through the mTOR/S6K1 pathway. Furthermore, Western blot analysis revealed a substantial increase in Ser636/639 phosphorylation of IRS-1 under OGD, a modification known to target IRS-1 for degradation. Both 3-MA and Rapamycin significantly reduced this phosphorylation, while simultaneously enhancing Tyr608 phosphorylation, a site associated with IRS-1 activation. These findings suggest that under ischemic stress, IRS-1 undergoes degradation primarily through autophagy linked with stress-induced phosphorylation at Ser636/639. Modulation of autophagy pathways or phosphorylation status could thus be a promising strategy to preserve IRS-1 function and support neuronal survival. Altogether, this study highlights IRS-1 as a potential neuroprotective factor and therapeutic target for the treatment of ischemic stroke.

Collections

Dissertationen/Habilitationen

Full item page

Exploring the protective mechanisms of insulin receptor substrate-1 under conditions of hypoxic-ischemic injury

Files

Date

Authors

Advisors/Reviewers

Further Contributors

Contributing Institutions

Publisher

Journal Title

Journal ISSN

Volume Title

Publisher

License

Quotable link

Abstract

Link to publications or other datasets

Description

Notes

Original publication in

Original publication in

Anthology

Collections

URI of original publication

Forschungsdaten

Series

Citation